Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Suspended × Carcinoma, Hepatocellular × Leukapheresis × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Triple Negative Breast Neoplasms 1 Carcinoma, Hepatocellular 1

Interventions

atezolizumab 2 Specimen Handling 2 Bevacizumab 2 netrin-1 inhibitor NP137 1 lenvatinib 1 fludarabine 1 Yttrium-90 1 Sorafenib 1 Nivolumab 1 Magnetic Resonance Spectroscopy 1 Leukapheresis 1 Folfox protocol 1 Cyclophosphamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06968195 2026-02-10

Autologous CAR T Cells Targeting GPC3 (RPCAR01) for the Treatment of Advanced or Metastatic GPC3 Expressing Hepatocellular Carcinoma

Roswell Park Cancer Institute

Phase 1 Suspended

Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡